logo
Select company
Select metric
$ -50.59MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
13
Sector
32
Industry
14
History
33
$ 1.52Close
$ 1.51 - $ 9.22 52-Week Range
Ticker Information

Ticker

LUNG

Company Name

PULMONX CORP

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

PULMONX CORP - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LUNG - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 2.5M$ -53.09M$ -50.59M
3/31/2025$ 2.85M$ -53.24M$ -50.39M
12/31/2024$ 3.34M$ -52.39M$ -49.05M
9/30/2024$ 3.69M$ -52.83M$ -49.14M
6/30/2024$ 4.1M$ -53.71M$ -49.62M
3/31/2024$ 4.27M$ -54.55M$ -50.29M
12/31/2023$ 4.23M$ -57.04M$ -52.81M
9/30/2023$ 4.28M$ -57.98M$ -53.7M
6/30/2023$ 4.21M$ -57.92M$ -53.71M
3/31/2023$ 4.12M$ -57.11M$ -52.99M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PULMONX CORP's latest trailing twelve months (TTM) EBITDA stands at $ -26.89M.
  • Over the past 5 years, PULMONX CORP's average EBITDA has been $ -47.65M.
  • The median EBITDA for PULMONX CORP during this period was $ -49.95M
  • PULMONX CORP reached its highest EBITDA over the past 5 years at $ -26.89M.
  • The lowest EBITDA recorded by PULMONX CORP in the same timeframe $ -53.71M

PULMONX CORP's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
TELA : TELA BIO INC $ -34.73MMYO : MYOMO INC $ -7.41MAPYX : APYX MEDICAL CORP $ -10.51MXTNT : XTANT MEDICAL HOLDINGS INC $ 4.58MBDSX : BIODESIX INC $ -27.69MSRTS : SENSUS HEALTHCARE INC $ 47KCTSO : CYTOSORBENTS CORP $ -7.31MSTRO : SUTRO BIOPHARMA INC $ -169.79MANIK : ANIKA THERAPEUTICS INC $ -48.18MMDAI : SPECTRAL AI INC $ -13.22M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for PULMONX CORP is calculated as follows: EBIT [ $ -28.84M ] + DepAmor [ $ 1.95M ]
(=) EBITDA [ $ -26.89M ]

LUNG - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -53.71M

Minimum

Jun 30, 2023

$ -26.89M

Maximum

Dec 31, 2020

$ -47.65M

Average

$ -49.95M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.79M with a standard deviation of $ 166.94M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.79M
median$ 8.83M
std$ 166.94M